New Risk • May 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Earnings have declined by 36% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩89.4b market cap, or US$59.3m). Announcement • Mar 11
LOGEN Co., Ltd., Annual General Meeting, May 22, 2026 LOGEN Co., Ltd., Annual General Meeting, May 22, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 37, baekja 3-gil, yongji-myeon, jeollabuk-do, gimje South Korea Announcement • Mar 10
Moda-InnoChips Co., Ltd. (KOSDAQ:A080420) agreed to acquire LOGEN Co., Ltd. (KOSDAQ:A033290) from Dae Myung Chemical Co., Ltd. in a reverse merger transaction for approximately KRW 150 billion. Moda-InnoChips Co., Ltd. (KOSDAQ:A080420) agreed to acquire LOGEN Co., Ltd. (KOSDAQ:A033290) from Dae Myung Chemical Co., Ltd. in a reverse merger transaction for approximately KRW 150 billion on March 9, 2026. The consideration consists of 76.38 million common equity of Moda-InnoChips Co., Ltd. at a ratio of 0.975411 per common equity of LOGEN Co., Ltd. As part of consideration, KRW 154.67 billion is paid towards common equity of LOGEN Co., Ltd.
The transaction is subject to subject to Korea Fair Trade Commission approval, approval by regulatory board / committee, approval of merger agreement by target board, approval of offer by acquirer shareholders, approval of offer by acquirer board and approval of offer by target shareholders. The transaction is expected to be completed in July 1, 2026. 
